Margaret M. Koehm, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 57 Prospect St, Nantucket, MA 02554 Phone: 508-325-9981 Fax: 508-325-8558 |
Diane R Pearl, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 57 Prospect St, Nantucket, MA 02554 Phone: 508-228-4748 |
George P Butterworth, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 57 Prospect St, Nantucket, MA 02554 Phone: 508-228-3200 Fax: 508-228-3891 |
Timothy J Lepore, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 57 Prospect St, Nantucket, MA 02554 Phone: 508-228-9053 |
James G Hinson, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 57 Prospect St, Nantucket, MA 02554 Phone: 508-325-9981 |
News Archive
Stereotaxis, Inc. announced today that it has been awarded $1.5 million in grants under the Qualifying Therapeutic Discovery Project Program that was enacted under the Patient Protection and Affordable Care Act of 2010.
A new prototype for medicated chewing gum has been developed for motion sickness that may offer many advantages over conventional oral solid dosage forms. About 33 percent of people are susceptible to motion sickness in mild circumstances and 66 percent are affected in more severe conditions.
Noted bariatric surgeon Michael Feiz, M.D., F.A.C.S., believes that there's no time like American Diabetes Month to point out that weight loss surgery is the most effective weapon obese people have in the battle against diabetes.
Metabasis Therapeutics, Inc. (Nasdaq: MBRX) announced today that on September 15, 2009, the Company received a letter from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq"), notifying the Company that based upon the closing bid price of its common stock for the last 30 consecutive business days, the Company did not maintain a minimum closing bid price of $1.00 per share or more that is required for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2).
Measuring a woman's bone mineral density can provide additional information that may help more accurately determine a woman's risk of developing breast cancer. That is the conclusion of a new study published in the September 1, 2008 issue of CANCER, a peer-reviewed journal of the American Cancer Society.
› Verified 1 days ago